Introduction

British American Tobacco plc is one of the largest global tobacco companies and a core FTSE 100 dividend payer, with a share price that has strengthened over the past year as investors have revisited the balance of income and transition risk in the stock.

The Financial Times data dated 20 April 2026 shows British American Tobacco (LSE:BATS) at 4,211.00 pence, a 1.67% intraday gain on a day when the wider index fell 0.67%. Over twelve months, shares are up 33.09%, ahead of the FTSE 100's 28.04% advance.

This article explores what is driving the improved performance and how investors might frame the business from here.

Company overview

British American Tobacco plc is a global consumer goods company with a leadership position in traditional tobacco and a steadily growing portfolio of next-generation products, including vapour, heated tobacco and modern oral nicotine categories.

The group operates across a broad set of geographies, with the US, Europe and emerging markets all contributing to revenues and cash flows. The traditional cigarette business continues to generate substantial cash, which supports investment in category reduced-risk alternatives and shareholder returns.

The balance between managing decline in combustible volumes and scaling new-category revenues is central to the strategic and investor narrative, alongside the group's strong dividend and balance sheet positioning.

Recent share price performance

A 33.09% twelve-month share-price gain is strong for a mature, dividend-focused tobacco name and reflects a mix of improved sentiment, supportive capital return, and more confidence in the company's ability to grow new-category revenues.

The 1.67% intraday advance is notable on a weaker index day, underscoring the income and defensive qualities that investors can rotate into during less confident sessions.

Momentum over the last year

Momentum has been constructive, with BATS benefiting from a clearer view on next-generation product economics and disciplined pricing in combustibles.

A 33% twelve-month gain for a mature tobacco major is typically built on a combination of capital return, stable earnings and sentiment rehabilitation.

Sector and company-specific drivers

Drivers include combustible pricing and volume trends, new-category revenue growth and profitability, regulatory developments in key markets such as the US, and currency effects on translated earnings.

Capital allocation — particularly buybacks, deleveraging and dividend trajectory — remains central to how investors frame the stock.

Investor sentiment

Sentiment towards British American Tobacco has improved as next-generation product economics have become easier to underwrite and as the dividend yield has remained attractive.

The strong intraday move reinforces its role as a defensive large cap in investor portfolios.

Risks and opportunities

Risks include regulatory change in combustible and next-generation products, FX volatility, pricing pressure in individual markets, and the structural decline of combustible volumes.

Opportunities include continued growth in new-category revenues, margin expansion as those categories mature, and ongoing capital return.

Wider industry and macro context

The global tobacco environment is being reshaped by regulatory frameworks that vary widely by geography, with next-generation product regulation particularly active in the US, Europe and parts of Asia.

Currency volatility is an important consideration for a group with such a broad international footprint, with sterling's moves versus the dollar and emerging-market currencies influencing reported results.

Against the FTSE 100's 28.04% twelve-month gain, BATS's 33.09% return contributes positively to the index's overall performance and underscores the continued relevance of mature dividend payers.

Balanced outlook

A balanced outlook for British American Tobacco combines continued cash generation and capital return with the need to keep executing on new-category growth to justify the re-rating.

The bull case is that investors continue to see BATS as a high-quality income name with improving growth optionality. The cautious case centres on regulatory risk and the challenge of managing declining combustible volumes.

Conclusion

British American Tobacco has strengthened meaningfully over the past year, with a 33.09% twelve-month gain and a 1.67% intraday lift that reinforce its standing as a core FTSE 100 income name.

For LSE:BATS investors, the FT data from 20 April 2026 at 4,211p captures a business at a more confident point in its transition than it was a year ago, with the outlook closely tied to capital return and next-category execution.